Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2012061410031N1Phase 3Completed
Phase 3 trial of ascorbic acid in brain death, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Gene expression of proinflammatory cytokines. Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2012061410031N1.